Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model

Ripple-backed XRP treasury firm eyes Nasdaq debut with $1B plan

Is Jabil Stock Outperforming the S&P 500?

JPMorgan cuts S&P 500 target as analysts say the domino effects from oil-price shock aren’t baked in

Should You Buy the Vanguard S&P 500 ETF After the Recent Stock Market Sell-Off? History Offers a Crystal-Clear Answer.

Wall Street falls as oil surge stokes inflation fears; Russell 2000 slips